The highly anticipated new Retatrutide 20mg device is now entering the market in the UK. Currently , access is limited and primarily via specialist healthcare providers participating in clinical studies . While a full, widespread commercial rollout date remains tentative, sources suggest that those eligible could be permitted to receive the drug vi